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Background: Exposure to traffic-related air pollution (TRAP) is considered a trigger for acute cardiovascular events.
Diesel Exhaust (DE) is a major contributor to TRAP in the world. We evaluated the effect of DE inhalation on
circulating blood cell populations, hematological indices, and systemic inflammatory cytokines in humans using a
specialized facility.
Methods: In a randomized double-blind crossover study balanced to order, 17 metabolic syndrome (MetS) and 15
healthy subjects inhaled filtered air (FA) or DE exposure in two-hour sessions on different days with a minimum
2-week washout period. We collected blood pre-exposure, 7, and 22 hours after exposure initiation and measured
the complete blood count and differential. We performed multiplex cytokine assay to measure the changes in the
systemic inflammatory cytokines, and endothelial adhesion molecules (n=15). A paired analysis compared the effect
of DE and FA exposures for the change from pre-exposure to the subsequent time points.
Results: A significant increase in the hematocrit was noted 7 hrs after DE [1.4% (95% CI: 0.9 to 1.9%)] compared to
FA exposure [0.5% (95% CI: -0.09 to 1.0%); p=0.008. The hemoglobin levels increased non-significantly at 7 hrs post
DE [0.3 gm/dL (95% CI: 0.2 to 0.5 gm/dL)] versus FA exposure [0.2 gm/dL (95% CI: 0 to 0.3 gm/dL)]; p=0.06.
Furthermore, the platelet count increased 22 hrs after DE exposure in healthy, but not in MetS subjects [DE: 16.6
(95% CI: 10.2 to 23) thousand platelets/mL versus [FA: 3.4 (95% CI: -9.5 to 16.3) thousand platelets/mL)]; p=0.04. No
DE effect was observed for WBC, neutrophils, lymphocytes or erythrocytes. Using the multiplex assay, small
borderline significant increases in matrix metalloproteinase-9, interleukins (IL)-1beta, 6 and 10 occurred 7 hrs post
exposure initiation, whereas E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule −1,
and myeloperoxidase 22 hrs post exposure.
Conclusions: Our results suggest that short-term DE exposure results in hemoconcentration and thrombocytosis,
which are important determinants of acute cardiovascular events. Multiplex assay showed a non-significant increase
in IL-1β and IL-6 immediately post exposure followed by myeloperoxidase and endothelial activation molecules.
Further specific assays in a larger population will improve our understanding of the systemic inflammatory
mechanisms following acute exposure to TRAP.
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Table 1 Demographic information of the study
participants




Age, (years) 28 ± 8 40 ± 8
Gender, M:F 11:2 8:6
Race (Caucasian: other) 10:3 8:3
BMI (kg/m2) 24.7 ± 1.5 40.1 ± 8.1
SBP (mm Hg) 115 ± 9 120 ± 9
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Exposure to traffic related air pollution has been shown
to trigger acute cardiovascular events and deaths primar-
ily due to myocardial infarction [1-4]. Although air pol-
lution consists of a heterogeneous mixture of gaseous
and particulate matter, adverse cardiovascular events are
most strongly associated with exposure to fine particu-
late matter (PM2.5), especially traffic sources of which
diesel exhaust (DE) is a principal source [5,6]. DE parti-
cles readily deposit within human alveoli and may con-
tribute to the biological toxicity eliciting systemic
inflammation and altered coagulability, or both. Air pol-
lutant components may induce these responses through
vascular endothelial cells, leukocytes, and/or platelets,
with expression of inflammatory cytokines, cellular ad-
hesion molecules, viscosity of blood, and coagulation
factors [7]. Activation of these inflammatory pathways
then potentially lead to increased vascular reactivity or
vasoconstriction, [8,9] endothelial dysfunction, [10] and
possibly plaque rupture triggering acute myocardial in-
farction or ischemia.
Prior panel studies and experimental studies have
shown that traffic related air pollution is associated
with increased systemic inflammatory cytokines [11].
Evidence from in-vitro studies demonstrated that par-
ticulate matter-exposed alveolar macrophages induce
cytokine expression [12] and experimental studies
assessed the bone marrow stimulatory response in terms
of cell counts [13]. We and other groups have used con-
trolled DE exposure studies to understand the mecha-
nisms of the effects of short-term exposure to DE on
biological pathways in humans.. We previously showed
that there was no effect of DE on markers of coagulation
in healthy subjects and in metabolic syndrome subjects
[14,15]. It is possible that DE exposure can activate sys-
temic inflammation in human subjects independent of
activating the coagulation cascade. Therefore, we hy-
pothesized that DE would affect peripheral blood cell
counts, hematological indices, and systemic cytokine
production in healthy and metabolic syndrome subjects.DBP (mm Hg) 71 ± 10 81 ± 7
Glucose (mg/dL) 89 ± 5 99.5 ± 9
Total Cholesterol
(mg/dL)
151 ± 30 193 ± 26
LDL (mg/dL) 88 ± 28 121 ± 22
HDL (mg/dL) 49 ± 12 37 ± 5
TGL (mg/dL) 74 ± 43 189 ± 127
Platelets (cells/mm3) 220 ± 43 223 ± 51
Total WBC (cells/mm3) 5.07 ± 1.36 5.48 ± 0.71
All of the values reported are mean ± SD unless otherwise noted. Differences
between healthy and metabolic syndrome subjects were statistically
significant, with the exception of race and sex (M-Male; F-Female). SBP
indicates systolic blood pressure; DBP, diastolic blood pressure; LDL, low-
density lipoprotein; HDL, high-density lipoprotein. DBP and triglyceride P≤0.01;
all others P≤0.001.Results
Baseline characteristics of subjects
Demographic information for the study participants is
shown in Table 1. Fifteen healthy subjects and seventeen
metabolic subjects were enrolled in the study. Of these,
thirteen subjects (five with metabolic syndrome) had
complete information for the multiplex assay. Fifteen
healthy subjects and 17 with metabolic syndrome had
complete blood counts with differential. The mean age
for the healthy subjects was 28 and that of the metabolic
subjects was 40. Levels of gaseous co pollutants were
low, with nitrogen dioxide ranging from 15–30 ppb andcarbon monoxide ranging between 0.2 to 0.7 ppm as
reported earlier [14].Systemic effects of diesel exhaust on the hematological
indices in the peripheral blood
We did not find any significant changes in the total white
blood cell count, neutrophils, or lymphocytes between
the exposures. Seven hours following exposure onset,
participants tended to have higher hematocrits, likely
due to hemoconcentration, regardless of exposure situ-
ation. However, the increase in the hematocrit 7-hours
post DE exposure was higher than with FA exposure
[Mean DE effect was 1.0% (95% CI: 0.3 to 1.6%);
p=0.008]. This effect was more pronounced in the meta-
bolic syndrome subjects [Mean DE effect was 1.1% (95%
CI: 0.2 to 2.1%); p=0.02] compared to healthy normal
subjects [Mean DE effect was 0.7% (95% CI: -0.4 to
1.9%); p=0.19] at 7 hours post exposure. (Table 2) We
also adjusted for perception of the exposure, which did
not affect these results. Similar increase was seen for
hemoglobin concentration with borderline significance
[Mean DE effect was 0.2 gm/dL (95% CI: -0.01 to 0.4 gm/
dL; p=0.06 for hemoglobin)], but not erythrocyte count.
(Table 2) Further, we also stratified our analysis based on
the oxidative stress gene; Glutathione S-Transferase M1
(GSTM1). Results indicated that the presence of the
GSTM1 wild-type genotype appeared to modify DE effects
on hematocrit, but not for the other endpoints particularly
platelets [Additional file 1: Table S1].
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in healthy subjects
The peripheral blood platelet count progressively in-
creased at 7 and 22 hours following DE exposure
among all the participants [Mean DE effect at 7
hours was 2.2 (95% CI: -4.2 to 8.6) thousand plate-
lets/mL) and at 22 hours was 5.5 thousand platelets/
mL (95% CI: -2.8 to 13.8 thousand platelets/mL)]
[Table 2]. The finding appeared larger in the healthy
subjects, for whom the increase in the platelet count
at 22 hours following DE exposure averaged 16.6
(95% CI: 10 to 23) thousand platelets/mL) compared
to filtered air (FA) [3.4 (95% CI: -9.5 to 16.3) thou-
sand platelets/mL)]. The mean DE effect in healthy
subjects was 13.2 (95% CI: 0.7 to 25.6) thousand
platelets/mL; p=0.04 increase at 22 hours. In con-
trast, the platelet count did not increase 22 hours
after exposure in the metabolic syndrome subjects
(Mean DE effect was (Mean DE effect was 0.9 (95%
CI: -10.5 to 12.3) thousand platelets/mL; p=0.9)
[Figure 1].
Effects of diesel exhaust on endothelial adhesion
molecules and inflammatory cytokines: results from the
multiplex cytokine assay
Using the multiplex assay, we found that the endothelial
cell adhesion molecules E- selectin, intercellular adhe-
sion molecule-1 (ICAM-1), and vascular cell adhesion
molecule-1 (VCAM-1) showed a small trend toward
increase in the plasma following DE exposure when
compared to FA exposure at 22 hours, but variability in
measurements was very high and no significant findings
were detected (Table 3). Changes related to DE in
multiplex measures of cytokines and inflammatory bio-
markers were not statistically significant but suggested
interesting trends. Myeloperoxidase increased slightlyTable 2 Changes in the hematological indices in all subjects e





Leukocytes (x1000 cells/μL) 26 0.4 ± 0.2 0.4 ± 0.2 −0.0 (−
Neutrophils (x1000 cells/μL) 24 0.4 ± 0.1 0.5 ± 0.2 0.0 (−
Lymphocytes (x1000 cells/μL) 25 0.03 ± 0.1 −0.01 ± 0.1 −0.04 (
Monocytes (x1000 cells/μL) 24 0.01 ± 0.02 −0.01 ± 0.03 −0.02 (
Erythrocytes (million cells/μL) 30 0.1 ± 0.02 −0.2 ± 0.2 −0.2 (−
Platelets (x1000 cells/μL) 24 9.2 ± 3.4 11.4 ± 2.8 2.2 (−
Hemoglobin (gm/dL) 24 0.2 ± 0.1 0.3 ± 0.1 0.2 (−
Hematocrit (%) 26 0.5 ± 0.3 1.4 ± 0.2 1 (0.3
Data are shown for the absolute mean differences from pre-exposure to 7 hours (Δ
refers to the effect attributable to DE calculated as [(Post –pre DE exposure - (Post-
*Indicates a P-value of 0.008; SE represents standard error; CI – Confidence Interval.with DE at both time points, while MMP-9 was only ele-
vated at 7 hours after exposure and adiponectin only at
the 22-hour time point. Among the inflammatory cyto-
kines, interleukin-1beta (IL-1β) and IL-10 increased at 7
and 22 hours post DE exposure initiation. IL-6 increased
1.1 fold immediately after exposure followed by a decline
24 hours later (Table 4).
Due to concern regarding the imprecision of the multi-
plex assay, we repeated IL-6 measurements in ten of these
participants using a widely used specific ELISA system. We
found that the mean change in the IL-6 level following
DE exposure was increased at 7 hours following DE [0.6
pg/mL, (95% CI: -0.1 to 1.3 pg/mL)]; but not following
FA [0.1 pg/mL, (95% CI: -0.3 to 0.4 pg/mL)] at 7 hours
post-exposure.Discussion
In this randomized crossover study, we found that a
two-hour exposure to diesel exhaust in a controlled
exposure facility resulted in a significant increase in
the hematocrit immediately post-exposure without an
increase in erythrocyte number. This increase appeared
more pronounced in the metabolic syndrome subjects.
Healthy, but not metabolic syndrome subjects demon-
strated an increase in platelet count a day following DE
exposure, without any change in other measured
circulating blood cell fractions. Using a multiplex assay,
we observed small and not significant increases in sev-
eral proteins with DE compared to FA, including circu-
lating endothelial adhesion molecules, myeloperoxidase,
adiponectin, interleukins-1β, 6, and 10. While the
finding would not be robust to multiple testing correc-
tions, the increase in IL-1β immediately post-exposure
achieved borderline statistical significance in standard
assessment.xposed to DE and Filtered Air (FA)
effect
eline - 7 h
5% CI)
n Change from baseline to 22 h
Mean ± SE
DE effect
Δ baseline - 22 h
(95% CI)Filtered air DE-200
0.3 to 0.3) 24 0.03 ± 0.1 0.1 ± 0.2 0.1 (−0.3 to 0.4)
0.4 to 0.4) 24 0.2 ± 0.1 0.2 ± 0.1 0.1 (−0.3 to 0.4)
−0.2 to 0.1) 23 −0.1 ± 0.05 −0.1 ± 0.04 −0.03 (−0.2 to 0.1)
−0.1 to 0.1) 21 −0.03 ± 0.02 −0.002 ± 0.04 0.03 (−0.1 to 0.1)
0.7 to 0.2) 28 0.1 ± 0.03 0.2 ± 0.3 0.1 (−0.5 to 0.7)
4.2 to 8.7) 22 4.5 ± 2.9 10.1± 2.6 5.5 (−2.8 to 13.8)
0.0 to 0.4) 24 0.3 ± 0.1 0.5 ± 0.1 0.1 (−0.1 to 0.4)
to 1.6)* 23 1.6 ± 0.4 1.1 ± 0.3 0.5 (−0.5 to 1.4)
Baseline-7 h) and 22 hours (Δ Baseline-22 h) of exposure initiation. DE effect
pre) FA exposure] displayed as the absolute change in each of the indices.
Figure 1 Absolute Platelet Count in Healthy Normal Subjects (A) and Metabolic Syndrome Subjects (B) following exposure. Figure
showing the distribution of the platelet count at the different time points in (A) Healthy subjects and (B) Metabolic Syndrome subjects. Each
panel depicts medians (bars) and interquartile ranges (whiskers) for platelet count associated with each exposure at baseline (pre-exposure) and
22 hours post exposure initiation. Crosses above the panels represent those that are outside of the interquartile range; * indicates P=0.04 for the
difference between DE pre-exposure and 22hours post exposure in healthy normal subjects. FA=filtered air; DE=200 μg/m3 (PM2.5) DE.
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hematological indices, circulating peripheral cell count and
a variety of inflammatory mediators in a chronological
manner in humans following DE exposure. DE is a major
contributor to traffic related pollution and contains higher
fine particulate content. Therefore, our findings provide
some support to the hypothesis that acute exposure to
traffic related air pollution initiates hemoconcentration, sys-
temic inflammatory process activating the endothelial–
blood cell interface, and increases circulating platelets. All
these biological processes are potential important steps in
mediating adverse cardiovascular events associated with
fine particulate matter exposure [5].Our finding of a rapid increase in hematocrit without
any changes in erythrocytes is in contrast to Seaton’s
study that first showed a negative association between 3-
day average personal PM10 exposures and blood parame-
ters such as hemoglobin, packed red cell volume [16,17].
This striking difference could be due to the different
specific concentrations and the experimental setting that
we employed to study the acute effects of traffic related
air pollutants. Other experimental studies have reported
peripheral blood counts, but not hematocrit or hemoglobin
from normal healthy subjects. Those studies have also ex-
amined the systemic markers in humans for only up to
6hrs [18,19]. It is unclear how fine particulate matter
Table 3 Endothelial activation markers measured by the multiplex assay in subjects exposed to DE and FA
Endothelial
biomarkers
N Δ Baseline - 7 h
Fold change ± SE (pg/dl)
DE Effect (Δ Baseline - 7 h)
[fold change] (95%
confidence interval)
N Δ Baseline - 22 h
Fold change ± SE (pg/dl)
DE Effect (Δ Baseline - 22 h)
[fold change] (95%
confidence interval)
Filtered air DE-200 P-values Filtered air DE-200 P-values
E-selectin 15 0.0 ± 0.1 0.02 ± 0.1 0.02 (95% CI: -0.3 to 0.3) 15 0.0 ± 0.1 0.1 ± 0.1 0.1 (95% CI: -0.2 to 0.4)
P=0.8 P=0.4
ICAM-1 15 0.0 ± 0.1 0.1 ± 0.1 0.2 (95% CI: -0.3 to 0.6) 17 0.04 ± 0.1 0.1 ± 0.1 0.1 (95% CI: -0.3 to 0.5)
P=0.5 P=0.6
VCAM-1 15 0.02 ± 0.1 0.1 ± 0.1 0.03 (95% CI: -0.2 to 0.3) 17 −0.1± 0.1 0.1± 0.1 0.2 (95% CI: -0.1 to 0.4)
P=0.8 P=0.2
Data are shown for the mean log2 differences from pre-exposure to 7 hours (Δ Baseline-7 h) and 22 hours (Δ Baseline-22 h) of exposure initiation. SE represents
standard error. DE effect refers to the effect attributable to DE calculated as [(Post –pre DE exposure - (Post-pre) FA exposure] for the log2 transformed values to
obtain fold changes. Positive difference indicates that change in a given marker was relatively more positive over DE-exposure interval, as compared to change
over FA exposure interval.
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late that this could be due to a combination of mechanisms
such as volume status or stress [20-22] that could affect the
blood viscosity. It is unlikely that our results could be
influenced purely by our subjects’ fluid intake, as they go
through much of the study in a fasting state, identical in
each exposure day (DE or FA), and blinded to exposure
status, and analyses compare the same time of day for
each exposure. Since only DE exposure resulted in a
significant hemoconcentration, it implies a direct ef-
fect on hemoconcentration, though it is also possible
that DE exposure was associated with less desire to
consume fluids.
Our recent observation of a 5mm Hg increase in the
systolic blood pressure immediately after exposure to
DE also indicates sympathetic nervous system mediated
effects of PM2.5 and future studies will address these
questions more specifically [23].
Few studies have addressed the direct effect of PM2.5
and other ambient air pollutants on platelets. In our
study, we found that inhalation of DE in healthy subjects
increased platelet count 22 hours following exposure. It
is of note that we did not observe an increase in platelets
in the metabolic subjects, who were also older and may
have an underlying inflammatory process or impaired
bone marrow function which could blunt the response
seen in the normal healthy subjects (Figure 1). We previ-
ously reported little effect of DE on markers of throm-
bosis including D-Dimer, von-Willebrand factor in
metabolic syndrome subjects, [14] or in healthy subjects
[15]. In contrast, another group has shown that exposure
to DE results in impaired fibrinolysis and recently
showed that DE inhalation increases ex vivo thrombus
formation and in vivo platelet activation in healthy sub-
jects [24]. Our observations could be seen as at odds
with these prior findings, but might also be due to differ-
ences in exposure characteristics or differences in the
molecular targets of our outcome measures. Similar to
the human experimental studies, animal studies showedthat mice exposed to concentrated ambient particles had
a significant increase in their platelet count with evi-
dence of platelet activation [25]. Both arterial and ven-
ous thrombosis were noted with increased platelet
aggregation in hamsters treated with intra-tracheal in-
stillation of DE particles [26]. Although, we have only
seen an increase in the platelet count, this is most likely
the first process for thrombogenesis, or could be due to
a direct bone marrow stimulatory effect as demonstrated
in other studies [12] or a reactive thrombocytosis from a
systemic inflammatory response.
In the multiplex luminex assay, the trend toward
an increase in the endothelial adhesion molecules (E-
selectin, ICAM-1, VCAM-1) and inflammatory cytokines
(such as interleukin 1β, interleukin-6, interleukin-10,
myeloperoxidase, and matrix metalloproteinase-9) are
fairly consistent with other air pollution studies; none of
these findings were statistically significant and none
were robust to adjustment for multiple comparisons.
Epidemiological study from children in the Mexico City
observed significant increases in inflammatory mediators
and vasoconstrictors, including tumor necrosis factor
(TNF) alpha, prostaglandin, C-reactive protein, interleukin-
1β, and endothelin-1, and down regulation of endothelial
adhesion molecules compared to the children from a less
polluted city [27]. An in vitro experiment using DE particles
caused an inflammatory response in macrophages charac-
terized by increased IL-8 and TNF-α concentration. This
inflammatory condition generated by macrophages in re-
sponse to DEP was a potent activator of endothelial cells
than direct particle treatment [28,29].
All the results noted in our current study provide
some insights into the mechanisms underlying the
short-term exposure to air pollution and cardiovascular
diseases. While prior experimental studies in animals
and humans have shown that exposure to fine particu-
late matter results in atherosclerosis progression
[30-32]. Less is known about the association between
particulate matter exposure and atherothrombosis.
Table 4 Inflammatory cytokines measured by the multiplex assay in humans exposed to DE and FA
Inflammatory
cytokines














Filtered air DE-200 Filtered air DE-200
P-values P-values
Myeloperoxidase 16 0.2 ± 0.2 0.4 ± 0.3 0.2 16 0.01 ± 0.2 0.4 ± 0.2 0.4
(95% CI: -1.1 to 0.7) (95% CI: -0.2 to 0.9)
P=0.7 P=0.2
Adiponectin 16 0.1 ± 0.2 −0.02 ± 0.1 0.1 15 −0.1 ± 0.2 0.2 ± 0.1 0.3
(95% CI: -0.4 to 0.6) (95% CI: -0.3 to 0.8)
P=0.6 P=0.3
MMP-9 14 0.0 ± 0.1 0.3 ± 0.2 0.3 15 0.01 ± 0.1 −0.1 ± 0.1 −0.1
(95% CI: -0.2 to 0.8) (95% CI: -0.6 to 0.3)
P=0.2 P=0.5
MCP-1 15 −0.2 ± 0.1 −0.2 ± 0.1 −0.01 15 −0.2 ± 0.1 −0.2 ± 0.1 −0.01
(95% CI: -0.3 to 0.2) (95% CI: -0.2 to 0.2)
P=0.9 P=0.9
VEGF 15 0.1 ± 0.1 0.1 ± 0.1 0.02 16 0.1 ± 0.1 0.1 ± 0.1 0.01
(95% CI: -0.2 to 0.2) (95% CI: -0.1 to 0.1)
P=0.6 P=0.7
Pro-BNP 5 0.3 ± 0.2 −0.2 ± 0.3 −0.4 6 0.1 ± 0.3 −0.1 ± 0.3 −0.2
(95% CI: -1.5 to 0.7) (95% CI: -1.0 to 0.6)
P=0.9 P=0.1
TNF-α 15 −0.1 ± 0.04 −0.1 ± 0.1 0.02 15 0.0 ± 0.1 −0.03 ± 0.1 −0.03
(95% CI: -1.4 to 0.2) (95% CI: -0.2 to 0.1)
P=0.8 P=0.5
IL-1β 9 −0.3 ± 0.2 0.1 ± 0.1 0.5 11 −0.2 ± 0.3 0.1 ± 0.3 0.3
(95% CI: -0.01 to 1) (95% CI: -1.1 to 2 )
P=0.06 P=0.9
IL-6 11 −0.04 ± 0.1 1.1 ± 0.7 1.1 8 0.2 ± 0.1 −0.1 ± 0.1 −0.3
(95% CI: -0.7 to 3) (95% CI: -0.6 to 0.1)
P=0.6 P=0.1
IL-8 15 −0.3 ± 0.1 −0.2 ± 0.2 0.1 16 −0.2 ± 0.1 −0.3 ± 0.2 −0.1
(95% CI: -0.3 to 0.6) (95% CI: -0.5 to 0.3)
P=0.8 P=0.9
IL-10 15 −0.3 ± 0.1 −0.01 ± 0.1 0.3 16 −0.1 ± 0.1 0.1 ± 0.1 0.2
(95% CI: -0.1 to 0.6) (95% CI: -0.3 to 0.6)
P=0.2 P=0.5
Data are shown for the mean log2 differences from pre-exposure to 7 hours (Δ Baseline-7 h) and 22 hours (Δ Baseline-22 h) of exposure initiation. DE effect refers
to the effect attributable to DE calculated as (Post –pre DE exposure)-(Post-pre FA exposure) for the log2 transformed values to obtain fold changes. Positive
difference indicates that the change in given marker was relatively more positive over DE-exposure interval, as compared to change over FA exposure interval.
SE - Standard Error; CI - Confidence Interval.
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bosis, procoagulation, endothelial erosion, and possibly in-
creased viscosity, typically occluding the lumen acutely
leading to acute events such as unstable angina, myocardial
infarctions [33-35]. We also noted an increase in markers
of neutrophil activation such as myeloperoxidase and
matrix metalloproteinase-9, but not increased neutrophil
count suggesting that DE exposure could promote systemicinflammation by activating neutrophils than by increasing
their production. These mechanisms are proposed based
on previous epidemiological studies that showed an associ-
ation between short-term increases in traffic related air pol-
lution exposure and increased incidence of myocardial
infarction [1,35] and deep venous thrombosis [36]. While
there are not many human experimental studies that have
shown an association between air pollution exposure and
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studies have shown an association between elevated
hematocrit and coronary artery disease suggesting that ele-
vated hematocrit is associated with a greater risk of acute
coronary syndromes, which is hypothesized to be from in-
creased whole blood viscosity [37-39]. Similar to this, a
panel study of elderly patients with CAD showed an
increase in inflammatory cytokines (interleukin-6), oxida-
tive biomarkers (myeloperoxidase), and platelet activation
[11,40].
Endothelial adhesion molecules have been considered
as markers of endothelial injury, [41] and have been as-
sociated with adverse cardiovascular events [42]. Endo-
thelial activation results in up regulation of leukocyte
adhesion proteins, attracts monocytes through release of
growth factors and pro-inflammatory cytokines, and initiates
vascular inflammation [43]. However, in vivo intra-vital mi-
croscopy studies have shown that platelet-endothelium ad-
hesion can occur in intact endothelium without activation
of the coagulation cascade [44] through activation of
platelet and endothelial adhesion molecules like ICAM-1,
VCAM-1, and E-selectin. Our previous study did not
show a significant increase in the pro-coagulant and pro-
thrombotic factors including von Willebrand factor, plas-
minogen activator inhibitor-1, and D-dimer, suggesting
that the activation of the coagulation cascade may not
occur as an early signal in our experimental model or
could be due to lack of adequate sensitivity of these as-
says [14,15]. Based on our observations, we hypothesize that
platelet-endothelial activation rather than procoagulation
could be one of the underlying mechanisms in subjects ex-
posed to DE that have to be confirmed in future studies.
The major strengths of our study are the use of a
rigorously controlled experimental design in which
each subject serves as their own control, the enroll-
ment of both healthy subjects and those with meta-
bolic syndrome, and observations at early (7 hours
following exposure initiation) and late (22 hours) time
points. Using a randomized crossover study design, we
were also able to study the effect of DE directly on a
broad range of cytokines and cell counts in a sequen-
tial manner.
Our study has several limitations. We would expect
an experimental study like ours to have more robust
abilities to detect an effect, if present, than observa-
tional designs, but our findings are not strongly posi-
tive. Several factors may explain this. Although we
were able to assess the effect on multiple cytokines
using the most sensitive assay, [45] there was wide
variability in the calculated concentrations. Prior
studies have validated the multiplex assay in compari-
son to the ELISA, using samples other than plasma
[46,47]. Other investigators who employed this assay
in inflammation research [48] and in non-diseasedhealthy subjects, [49] reported that their findings are
difficult to interpret due to the low sensitivity of this
assay from multiple interactions with other plasma
proteins and poor threshold of detection for the
inflammatory markers such as IL-1β, TNF-α and IL-6.
In addition to these, our study samples utilized for the
multiplex assay also came from a subset of heteroge-
neous population consisting of normal healthy sub-
jects and metabolic syndrome. Furthermore, our
experimental findings cannot distinguish if the source
of the inflammatory markers is pulmonary or sys-
temic in origin. It is also unclear from our study if
the increased platelet in the circulation is from bone
marrow stimulation or a reactive thrombocytosis
phenomenon due to increased inflammation. Hence,
to address these issues, we plan to use more
sensitive, specific ELISA assays for the endothelial
adhesion molecules, neutrophil inflammatory markers,
cytokines, and platelet activation assays in our future
studies. Clinical studies such as these are logistically
difficult, and the small number of participants seems
an obstacle to obtaining sufficient statistical power.
Nevertheless, we were well powered to detect clinic-
ally significant changes in our outcome parameters.Conclusions
In a well-controlled experimental setting using DE as a
model traffic-related air pollutant, our results suggest
that acute exposure to DE might result in an increase
in endothelial adhesion molecules, hemoconcentration,
and systemic inflammatory cytokines such as interleu-
kins 1β, 6, and 10, as early as 7 hours post-exposure
initiation, followed by thrombocytosis 22 hours after ex-
posure initiation. Taken together, these findings suggest
that platelet-endothelial activation may be an early path-
way for the evolution of vascular phenomena by which
traffic-related air pollutants trigger myocardial infarction
and ischemic stroke.Methods
Subject recruitment and inclusion criteria
Subjects were eligible to participate in the study if they
fulfilled the following inclusion criteria: age 18–49 years;
non-smoking status at least 6 months prior to recruit-
ment; no history of on-going medical care for heart dis-
ease or asthma; lack of arrhythmia or ischemia on
electrocardiograph (ECG); normal spirometry (MicroDL,
Micro Medical Ltd, Kent, UK); and having the metabolic
syndrome (3 or more of the following 5 criteria) [50] ele-
vated waist circumference [men, equal to or greater than
40 inches; women, equal to or greater than 35 inches];
elevated triglycerides [equal to or greater than 150 mg/
dl]; reduced HDL cholesterol [men, less than 40 mg/dl;
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[equal to or greater than 130/85 mm Hg]; elevated
fasting glucose [equal to or greater than 100 mg/dl]).
Subjects were required to be off blood thinning medica-
tions, statins, and antioxidants. Women of childbearing
age underwent a urine pregnancy test at screening and
before each exposure, and were instructed to practice ef-
fective contraception during the study. All subjects gave
a written informed consent prior to the screening
process. The consent form and study protocol were
approved by the University of Washington Human
Subjects Review Division.Study design
Using a randomized double-blinded crossover study, 17
subjects with metabolic syndrome and 15 healthy sub-
jects were exposed to FA or DE (at 200 μg PM2.5/m
3) in
two-hour sessions on different days after a 2-week wash-
out period. DE exposure was calibrated based on the
mass of particles less than 2.5 microns in diameter
(PM2.5), and measured continuously using a tapered
element oscillating microbalance. (TEOM 1400A PM2.5,
Rupprecht & Patashnick Co., Albany, NY) Exhaust was
generated from a 2002 turbocharged direct injection 5.9-
L Cummins B series engine (6BT5.9G6, Cummins, Inc.,
Columbus, IN) via 100-kW generator distributed to a
116-m3 exposure room after a two-phase dilution of ex-
haust provided a total dilution of 400:1.
Temperature and relative humidity were maintained at
18°C and 60%, respectively for both filtered air and DE
exposures. Particle source composition (carbon and
trace elements) was similar to that of the U.S. Environ-
mental Protection Agency (EPA) light-duty diesel profile.
Based on multistage impactor-collected samples, the
facility's DE particle mass median diameter was 0.10 μm
(σg = 1.15) [51]. Particle count per cubic centimeter for
our exposure scenario was 2.8×103 for FA and 5.3×104
for DE exposures [23].
Subjects fasted overnight and during the exposure.
They ate a standardized meal, with the same food con-
tent and quantity, after each exposure. Exposure began
consistently within 30 min of 9 a.m. on weekdays and
lasted 2 hours, during which time subjects were resting.
We drew blood samples two hours prior to exposure ini-
tiation, 7 and 22 hours post exposure initiation. All re-
searchers, nurses and technicians participating in the
study were blinded to exposure type, with the exception
of the exposure engineer. To evaluate blinding adequacy,
subjects were asked during exposure to estimate the
level of DE in the chamber. We considered this percep-
tion of exposure in our analysis and used as a categorical
variable to adjust for the blood count analyses. All sub-
jects gave written informed consent. The University ofWashington Human Subjects Division approved the
consent form and study protocol.
Multiplex bead-based cytokine assays
Plasma samples were analyzed using the Lincoplex Hu-
man Cardiovascular Disease Panel 1 (CVD1) and Panel
3 (CVD3) (currently called the MILLIPLEX MAP Hu-
man Cardiovascular Disease Panel) and the Human Cus-
tom Immunoassay 3-plex kit (Millipore, Billerica, MA)
according to the manufacturer’s instructions. The CVD1
was used to measure cytokines soluble E-selectin, soluble
VCAM-1, soluble ICAM-1, MMP-9, Myeloperoxidase
(MPO), and Adiponectin whereas CVD3 was to measure
cytokines IL-1, IL-6, IL-8, IL-10, TNF-α, MCP-1, NT-
proBNP and VEGF. Also, the Human Custom Immuno-
assay 3-plex was used to measure cytokines level of IL-1β,
IL-6, and MCP-1. Briefly, 25 μL of each standard from
series of 4-fold dilution and samples were incubated with
target capturing beads on a 96-well plate for 16 hours
at 4°C, followed by one hour of incubation with specific
biotinylated detection antibodies at room temperature.
Next, Streptavidin-Phycoerythrin was added to each well
and incubated for 30 minutes at room temperature. Filtra-
tion and washing were incorporated after each incubation
step with wash buffer using vacuum manifold. Samples
were re-suspended in sheath fluid prior to reading using
the Luminex 100TM (Austin, TX) suspension array reader.
Each sample was analyzed in duplicates. We ran this ana-
lysis on 13 healthy subjects and 5 metabolic subjects, but
the final number of samples for each analyte at the different
time points was dependent on the individual limit of
detection.
Human IL-6 assays
Quantitative analysis of IL-6 was performed using the
Quantikine High Sensitivity Human IL-6 ELISA kit
(R&D, Minneapolis, MN) according to the manufac-
turer’s instructions. Briefly, 100 μL of each standard
from series of 2-fold dilution and samples were incu-
bated on a 96-well microplate for two hours, followed by
two hours of incubation with IL-6. Washing were incor-
porated after each incubation steps. Substrate solution
was added to the samples and incubated for one hour,
followed by 30 minutes incubation of amplifier solution.
Finally, plates were read at 490nm with the Spectra Max
Plus (Molecular Devices, Sunnyville, CA) immediately
after addition of stop buffer. Each sample was analyzed
in duplicates.
CBC with differential count and genotyping
CBC with differential count was measured in an auto-
mated analyzer at the University of Washington Medical
Center clinical laboratories, Seattle, WA. We also used
the genomic DNA from the frozen buffy coat samples to
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(GSTM1) based on the allele-specific multiplex PCR
assay [Additional file 1: Table S1].
Statistical analysis
Descriptive data are shown as mean ± SD or as percent-
age. Cytokine analyses were performed following loga-
rithmic transformation to improve normality of data.
Paired t-test was performed comparing DE and FA expo-
sures for the change from pre-exposure to 7 hours or 22
hours after exposure initiation. We analyzed the change
attributed to DE exposure as [post-DE – pre-DE] –
[post-FA – pre-FA]. We also evaluated data for evidence
of carryover effects and adjusted for perception.
Additional file
Additional file 1: Table S1. Changes in the Hematocrit in subjects
exposed to Diesel Exhaust (DE) and Filtered Air (FA) based on the
Glutathione-S-Transferase M1 (GSTM1) status of the participants. P-values
are shown based on the paired t-test results from stratified analysis.
Interaction testing was not significant.
Abbreviations
PM2.5: Fine particulate matter; ICAM-1: Intercellular adhesion molecule;
VCAM-1: Vascular cellular adhesion molecule; E-selectin: E-selectin; IL-
6: Interleukin-6; IL-1β: Interleukin-1beta; TNF- α: Tumor necrosis factor-alpha;
MMP-9: Matrix Metalloproteinase-9; MCP-1: Monocyte Chemotactic Protein-1;
MPO: Myeloperoxidase; VEGF: Vascular Endothelial Growth Factor.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RMK performed data analysis, wrote, and edited the manuscript. JS
conceived the study, and supervised design and coordination of data
collection. HW carried out the Luminex multiplex assay analyses and the
ELISA for IL-6; FMF participated in the design of the experimental assays and
provided input on the results. CC provided input for data analysis and
editing the manuscript. DB and TB provided statistical consultation on the
data analysis. JDK had overall responsibility for the experiments, conceived
the study and its design and coordination, and edited the manuscript. All
authors read, corrected, and approved the manuscript.
Acknowledgements
We would like to express our sincere appreciation to Mary Aulet, who
coordinated the study and helped with the recruitment of the subjects and
Jim Stewart for operating the controlled exposure facility. This study was
funded by EPA grant RD-830954, NIEHS grants K24ES013195, K23ES1113901,
P30ES07033, and P50 ES015915.
Author details
1Departments of Medicine, University of Washington, Seattle, WA, USA.
2Environmental and Occupational Health Sciences, 3 Epidemiology University
of Washington, Seattle, WA, USA. 3Epidemiology, School of Medicine and
School of Public Health, University of Washington, Seattle, WA, USA.
Received: 16 October 2012 Accepted: 12 March 2013
Published: 26 March 2013
References
1. Peters A, Dockery DW, Muller JE, Mittleman MA: Increased particulate air
pollution and the triggering of myocardial infarction. Circulation 2001,
103:2810–2815.2. Peters A, von Klot S, Heier M, Trentinaglia I, Hormann A, Wichmann HE,
Lowel H: Exposure to traffic and the onset of myocardial infarction.
N Engl J Med 2004, 351:1721–1730.
3. Nawrot TS, Perez L, Kunzli N, Munters E, Nemery B: Public health
importance of triggers of myocardial infarction: a comparative risk
assessment. Lancet 2011, 377:732–740.
4. Mustafic H, Jabre P, Caussin C, Murad MH, Escolano S, Tafflet M, Perier MC,
Marijon E, Vernerey D, Empana JP, Jouven X: Main air pollutants and
myocardial infarction: a systematic review and meta-analysis. JAMA 2012,
307:713–721.
5. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV,
Holguin F, Hong Y, Luepker RV, Mittleman MA, et al: Particulate matter air
pollution and cardiovascular disease: an update to the scientific
statement from the american heart association. Circulation 2010,
121:2331–2378.
6. Charron A, Harrison RM: Fine (PM2.5) and coarse (PM2.5-10) particulate
matter on a heavily trafficked London highway: sources and processes.
Environ Sci Technol 2005, 39:7768–7776.
7. Mills NL, Tornqvist H, Robinson SD, Gonzalez MC, Soderberg S, Sandstrom T,
Blomberg A, Newby DE, Donaldson K: Air pollution and atherothrombosis.
Inhal Toxicol 2007, 19(Suppl 1):81–89.
8. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R,
Mittleman M, Samet J, Smith SC Jr, Tager I: Air pollution and
cardiovascular disease: a statement for healthcare professionals from the
Expert Panel on Population and Prevention Science of the American
Heart Association. Circulation 2004, 109:2655–2671.
9. Peretz A, Sullivan JH, Leotta DF, Trenga CA, Sands FN, Allen J, Carlsten C,
Wilkinson CW, Gill EA, Kaufman JD: Diesel exhaust inhalation elicits acute
vasoconstriction in vivo. Environ Health Perspect 2008, 116:937–942.
10. Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S, Boon
NA, Donaldson K, Sandstrom T, Blomberg A, Newby DE: Ischemic and
thrombotic effects of dilute diesel-exhaust inhalation in men with
coronary heart disease. N Engl J Med 2007, 357:1075–1082.
11. Delfino RJ, Staimer N, Tjoa T, Gillen DL, Polidori A, Arhami M, Kleinman MT,
Vaziri ND, Longhurst J, Sioutas C: Air pollution exposures and circulating
biomarkers of effect in a susceptible population: clues to potential
causal component mixtures and mechanisms. Environ Health Perspect
2009, 117:1232–1238.
12. van Eeden SF, Tan WC, Suwa T, Mukae H, Terashima T, Fujii T, Qui D,
Vincent R, Hogg JC: Cytokines involved in the systemic inflammatory
response induced by exposure to particulate matter air pollutants
(PM(10)). Am J Respir Crit Care Med 2001, 164:826–830.
13. Nemmar A, Al-Maskari S, Ali BH, Al-Amri IS: Cardiovascular and lung
inflammatory effects induced by systemically administered diesel exhaust
particles in rats. Am J Physiol Lung Cell Mol Physiol 2007,
292:L664–L670.
14. Carlsten C, Kaufman JD, Trenga CA, Allen J, Peretz A, Sullivan JH:
Thrombotic markers in metabolic syndrome subjects exposed to diesel
exhaust. Inhal Toxicol 2008, 20:917–921.
15. Carlsten C, Kaufman JD, Peretz A, Trenga CA, Sheppard L, Sullivan JH:
Coagulation markers in healthy human subjects exposed to diesel exhaust.
Thromb Res 2007, 120:849–855.
16. Seaton A, MacNee W, Donaldson K, Godden D: Particulate air pollution and
acute health effects. Lancet 1995, 345:176–178.
17. Seaton A, Soutar A, Crawford V, Elton R, McNerlan S, Cherrie J, Watt M,
Agius R, Stout R: Particulate air pollution and the blood. Thorax 1999,
54:1027–1032.
18. Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon
NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE: Diesel exhaust
inhalation causes vascular dysfunction and impaired endogenous
fibrinolysis. Circulation 2005, 112:3930–3936.
19. Barath S, Mills NL, Lundback M, Tornqvist H, Lucking AJ, Langrish JP,
Soderberg S, Boman C, Westerholm R, Londahl J, et al: Impaired vascular
function after exposure to diesel exhaust generated at urban transient
running conditions. Part Fibre Toxicol 2010, 7:19.
20. Austin AW, Patterson SM, von Kanel R: Hemoconcentration and
hemostasis during acute stress: interacting and independent effects.
Ann Behav Med 2011, 42:153–173.
21. Jern C, Wadenvik H, Mark H, Hallgren J, Jern S: Haematological changes
during acute mental stress. Br J Haematol 1989, 71:153–156.
Krishnan et al. Particle and Fibre Toxicology 2013, 10:7 Page 10 of 10
http://www.particleandfibretoxicology.com/content/10/1/722. de Boer D, Ring C, Carroll D: Time course and mechanisms of
hemoconcentration in response to mental stress. Biol Psychol 2006,
72:318–324.
23. Cosselman KE RMK, Oron AP, Jansen K, Peretz A, Sullivan JH, Larson TV,
Kaufman JD: Blood pressure response to controlled diesel exhaust
exposure in human subjects. Hypertension 2012, 59:943–948.
24. Lucking AJ, Lundback M, Mills NL, Faratian D, Barath SL, Pourazar J, Cassee
FR, Donaldson K, Boon NA, Badimon JJ, et al: Diesel exhaust inhalation
increases thrombus formation in man. Eur Heart J 2008, 29:3043–3051.
25. Wilson DW, Aung HH, Lame MW, Plummer L, Pinkerton KE, Ham W,
Kleeman M, Norris JW, Tablin F: Exposure of mice to concentrated
ambient particulate matter results in platelet and systemic cytokine
activation. Inhal Toxicol 2010, 22:267–276.
26. Nemmar A, Hoet PH, Dinsdale D, Vermylen J, Hoylaerts MF, Nemery B:
Diesel exhaust particles in lung acutely enhance experimental peripheral
thrombosis. Circulation 2003, 107:1202–1208.
27. Calderon-Garciduenas L, Villarreal-Calderon R, Valencia-Salazar G, Henriquez-
Roldan C, Gutierrez-Castrellon P, Torres-Jardon R, Osnaya-Brizuela N, Romero
L, Solt A, Reed W: Systemic inflammation, endothelial dysfunction, and
activation in clinically healthy children exposed to air pollutants.
Inhal Toxicol 2008, 20:499–506.
28. Shaw CA, Robertson S, Miller MR, Duffin R, Tabor CM, Donaldson K, Newby
DE, Hadoke PW: Diesel particulate-exposed macrophages cause marked
endothelial cell activation. Am J Respir Cell Mol Biol 2010.
29. Yang HM, Ma JY, Castranova V, Ma JK: Effects of diesel exhaust particles
on the release of interleukin-1 and tumor necrosis factor-alpha from rat
alveolar macrophages. Exp Lung Res 1997, 23:269–284.
30. Suwa T, Hogg JC, Quinlan KB, Ohgami A, Vincent R, van Eeden SF:
Particulate air pollution induces progression of atherosclerosis. J Am Coll
Cardiol 2002, 39:935–942.
31. Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, Aguinaldo JG,
Fayad ZA, Fuster V, Lippmann M, et al: Long-term air pollution exposure
and acceleration of atherosclerosis and vascular inflammation in an
animal model. JAMA 2005, 294:3003–3010.
32. Kunzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, Thomas D,
Peters J, Hodis HN: Ambient air pollution and atherosclerosis in Los
Angeles. Environ Health Perspect 2005, 113:201–206.
33. Fuster V, Moreno PR: Atherothrombosis as a systemic, often silent,
disease. Nat Clin Pract Cardiovasc Med 2005, 2:431.
34. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ: Atherothrombosis and
high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 2005,
46:937–954.
35. Zanobetti A, Schwartz J: Air pollution and emergency admissions in
Boston, MA. J Epidemiol Community Health 2006, 60:890–895.
36. Baccarelli A, Martinelli I, Zanobetti A, Grillo P, Hou LF, Bertazzi PA, Mannucci
PM, Schwartz J: Exposure to particulate air pollution and risk of deep
vein thrombosis. Arch Intern Med 2008, 168:920–927.
37. Brown DW, Giles WH, Croft JB: Hematocrit and the risk of coronary heart
disease mortality. Am Heart J 2001, 142:657–663.
38. Sorlie PD, Garcia-Palmieri MR, Costas R Jr, Havlik RJ: Hematocrit and risk of
coronary heart disease: the Puerto Rico Health Program. Am Heart J 1981,
101:456–461.
39. Gagnon DR, Zhang TJ, Brand FN, Kannel WB: Hematocrit and the risk of
cardiovascular disease–the Framingham study: a 34-year follow-up.
Am Heart J 1994, 127:674–682.
40. Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen DL, Kleinman MT,
Vaziri ND, Longhurst J, Zaldivar F, Sioutas C: Circulating biomarkers of
inflammation, antioxidant activity, and platelet activation are associated
with primary combustion aerosols in subjects with coronary artery
disease. Environ Health Perspect 2008, 116:898–906.
41. Lupattelli G, Lombardini R, Schillaci G, Ciuffetti G, Marchesi S, Siepi D,
Mannarino E: Flow-mediated vasoactivity and circulating adhesion
molecules in hypertriglyceridemia: association with small, dense LDL
cholesterol particles. Am Heart J 2000, 140:521–526.
42. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC,
Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB: Inflammatory markers and
the risk of coronary heart disease in men and women. N Engl J Med 2004,
351:2599–2610.
43. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 1999,
138:S419–S420.44. Gawaz M, Langer H, May AE: Platelets in inflammation and atherogenesis.
J Clin Invest 2005, 115:3378–3384.
45. Djoba Siawaya JF, Roberts T, Babb C, Black G, Golakai HJ, Stanley K, Bapela
NB, Hoal E, Parida S, van Helden P, Walzl G: An evaluation of commercial
fluorescent bead-based luminex cytokine assays. PLoS One 2008, 3:e2535.
46. dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL: Validation and
comparison of luminex multiplex cytokine analysis kits with ELISA:
determinations of a panel of nine cytokines in clinical sample culture
supernatants. J Reprod Immunol 2005, 66:175–191.
47. Prabhakar U, Eirikis E, Reddy M, Silvestro E, Spitz S, Pendley C 2nd, Davis HM,
Miller BE: Validation and comparative analysis of a multiplexed assay for
the simultaneous quantitative measurement of Th1/Th2 cytokines in
human serum and human peripheral blood mononuclear cell culture
supernatants. J Immunol Methods 2004, 291:27–38.
48. Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS, Kuchel GA: ELISA
and multiplex technologies for cytokine measurement in inflammation
and aging research. J Gerontol Biol Med Sci 2008, 63:879–884.
49. Dossus L, Becker S, Achaintre D, Kaaks R, Rinaldi S: Validity of multiplex-
based assays for cytokine measurements in serum and plasma from
"non-diseased" subjects: comparison with ELISA. J Immunol Methods 2009,
350:125–132.
50. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA,
Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al: Diagnosis and
management of the metabolic syndrome: an American Heart
Association/National Heart, Lung, and Blood Institute Scientific
Statement. Circulation 2005, 112:2735–2752.
51. Gould T, Larson T, Stewart J, Kaufman JD, Slater D, McEwen N: A controlled
inhalation diesel exhaust exposure facility with dynamic feedback
control of PM concentration. Inhal Toxicol 2008, 20:49–52.
doi:10.1186/1743-8977-10-7
Cite this article as: Krishnan et al.: A randomized cross-over study of
inhalation of diesel exhaust, hematological indices, and endothelial
markers in humans. Particle and Fibre Toxicology 2013 10:7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
